中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2001年
1期
39-42
,共4页
LI Zhishan%李之山%张汝刚%罗贤懋%魏慧娟%王迎红%陈风%冯益民
LI Zhishan%李之山%張汝剛%囉賢懋%魏慧娟%王迎紅%陳風%馮益民
LI Zhishan%리지산%장여강%라현무%위혜연%왕영홍%진풍%풍익민
食管肿瘤%癌,鳞状细胞%谷胱甘肽硫转移酶%钟瘤标志物
食管腫瘤%癌,鱗狀細胞%穀胱甘肽硫轉移酶%鐘瘤標誌物
식관종류%암,린상세포%곡광감태류전이매%종류표지물
目的研究谷胱甘肽硫转移酶-π(CST-π)在人食管鳞癌中的表达及其与食管鳞癌临床病理的相互关系。方法应用免疫组织化学方法和sandwich酶联免疫吸附测定法(enzyme linked immunosorbent assay, ELISA)对143例食鳞癌石蜡标本和43例食管鳞癌患者的术前及术后血清标本进行检测。结果 GST-π在人食管鳞癌石蜡标本和43例食管鳞癌患者的术前及术后血清标本异有极显著性(P〈0.01)。GST-π在高分化食管鳞癌中的表达显著高于其在低分公食管鳞癌中的表达(P〈0.05).GST-π在高分公食管鳞癌中的表达显著高天其在低分公食管鳞癌中的表达(P<0.05).食管鳞癌患者术前和术后血清CST-π含量平均值均显著高天正常人CST-π含量平均值,但两者差异无显著性(P<0.05).结论 GST-π含量平均值低于术前血清GST-π含量平均值,但两者差异著性(P<0.05).结论 GST-π是食管鳞癌的一个有应用价值的标志物,其与食管鳞癌的发生有关,可能是食管上皮癌变前的一个早期标志物.
目的研究穀胱甘肽硫轉移酶-π(CST-π)在人食管鱗癌中的錶達及其與食管鱗癌臨床病理的相互關繫。方法應用免疫組織化學方法和sandwich酶聯免疫吸附測定法(enzyme linked immunosorbent assay, ELISA)對143例食鱗癌石蠟標本和43例食管鱗癌患者的術前及術後血清標本進行檢測。結果 GST-π在人食管鱗癌石蠟標本和43例食管鱗癌患者的術前及術後血清標本異有極顯著性(P〈0.01)。GST-π在高分化食管鱗癌中的錶達顯著高于其在低分公食管鱗癌中的錶達(P〈0.05).GST-π在高分公食管鱗癌中的錶達顯著高天其在低分公食管鱗癌中的錶達(P<0.05).食管鱗癌患者術前和術後血清CST-π含量平均值均顯著高天正常人CST-π含量平均值,但兩者差異無顯著性(P<0.05).結論 GST-π含量平均值低于術前血清GST-π含量平均值,但兩者差異著性(P<0.05).結論 GST-π是食管鱗癌的一箇有應用價值的標誌物,其與食管鱗癌的髮生有關,可能是食管上皮癌變前的一箇早期標誌物.
목적연구곡광감태류전이매-π(CST-π)재인식관린암중적표체급기여식관린암림상병리적상호관계。방법응용면역조직화학방법화sandwich매련면역흡부측정법(enzyme linked immunosorbent assay, ELISA)대143례식린암석사표본화43례식관린암환자적술전급술후혈청표본진행검측。결과 GST-π재인식관린암석사표본화43례식관린암환자적술전급술후혈청표본이유겁현저성(P〈0.01)。GST-π재고분화식관린암중적표체현저고우기재저분공식관린암중적표체(P〈0.05).GST-π재고분공식관린암중적표체현저고천기재저분공식관린암중적표체(P<0.05).식관린암환자술전화술후혈청CST-π함량평균치균현저고천정상인CST-π함량평균치,단량자차이무현저성(P<0.05).결론 GST-π함량평균치저우술전혈청GST-π함량평균치,단량자차이저성(P<0.05).결론 GST-π시식관린암적일개유응용개치적표지물,기여식관린암적발생유관,가능시식관상피암변전적일개조기표지물.
Objective To evaluate the expression of glutathione S-transferase-π(GST-π)in human esophageal squamous cell carcinoma (ESGG)and ith correlation with the clinicopathological data,Methods Immuuohistochemical method(Labeled avidin biotin metod)and ELISAwere used to detect the expression of glu-tathione S-transferase-πin 143 cases of formalin fixed,paraffin embedded ESCC tissue sections. Serum GST-πwas determined before and after operation in 43 patients with ESCC. Resuits GST-πwas positively stained immunohistochemically in 58.7%(84/143)of ESGG and 79.6%(109/139)of surrounding noncancerous esophageal tissues(P<0.05).The expression level of GST-π was significantly higher in well differentiated than poorly differentiated carcinomas(P<0.05).No significant correlation was observed between CST-πLevels and lymph node metastasis,pathological staging or long term survival. The preoperative and postoperative mean serum GST-πlevel in postoperative patients was lower than that in preoperative patients ,but the differ-ence was not significant. Conclusion GST-πis a useful tumor marker for human ESCC.